Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity

Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin, paclitaxel, docetaxel, etoposide and oxaliplatin, cancer cells are able to obtain chemoresistance that limits DOX efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Ashrafizadeh, Milad, Zarrabi, Ali, Hashemi, Farid, Zabolian, Amirhossein, Saleki, Hossein, Bagherian, Morteza, Azami, Negar, Bejandi, Atefe Kazemzade, Hushmandi, Kiavash, Ang, Hui Li, Makvandi, Pooyan, Khan, Haroon, Kumar, Alan Prem
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7697177/
https://ncbi.nlm.nih.gov/pubmed/33187385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111084
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados